Iovance Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0JDK Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
20 Feb 24	BuyUS$292,800	Iain Dukes	Individual	32,000	US$9.15
20 Feb 24	BuyUS$2,287,500	Merrill McPeak	Individual	250,000	US$9.15
20 Feb 24	BuyUS$45,750,000	Wayne Rothbaum	Individual	5,000,000	US$9.15
18 Sep 23	BuyUS$55,600	Merrill McPeak	Individual	10,000	US$5.56
15 Sep 23	BuyUS$26,500,000	Wayne Rothbaum	Individual	5,000,000	US$5.30

Insider Trading Volume

Insider Buying: 0JDK insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0JDK?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	13,478	0.00483%
Individual Insiders	29,171,880	10.4%
General Public	34,672,638	12.4%
VC/PE Firms	39,218,846	14%
Institutions	176,230,201	63.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.7%.

Top Shareholders

Top 25 shareholders own 67.82% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.1%	Wayne Rothbaum	28,067,333	US$331.3m	21.7%	no data
8.17%	The Vanguard Group, Inc.	22,812,820	US$269.2m	3.02%	no data
7.16%	MHR Fund Management LLC	19,997,103	US$236.0m	0%	25.93%
6.88%	Perceptive Advisors LLC	19,221,743	US$226.9m	60.5%	5.27%
6.83%	BlackRock, Inc.	19,071,756	US$225.1m	3.78%	no data
5.88%	State Street Global Advisors, Inc.	16,424,388	US$193.8m	-1.84%	0.01%
2.4%	Avoro Capital Advisors LLC	6,700,000	US$79.1m	0%	1.15%
1.88%	Pictet Asset Management Limited	5,263,309	US$62.1m	-23.9%	0.04%
1.8%	Geode Capital Management, LLC	5,037,098	US$59.4m	6.06%	0.01%
1.73%	Artisan Partners Limited Partnership	4,827,670	US$57.0m	-4.15%	0.05%
1.69%	OrbiMed Advisors LLC	4,707,458	US$55.6m	0%	0.78%
1.41%	Balyasny Asset Management L.P.	3,926,159	US$46.3m	-12.3%	0.13%
1.26%	Dimensional Fund Advisors LP	3,516,987	US$41.5m	-11.6%	0.01%
1.18%	BioImpact Capital LLC	3,289,470	US$38.8m	0.06%	7.43%
1.17%	T. Rowe Price Group, Inc.	3,276,602	US$38.7m	-8.91%	no data
1.1%	Morgan Stanley, Investment Banking and Brokerage Investments	3,085,797	US$36.4m	42.6%	no data
1.01%	Goldman Sachs Group, Investment Banking and Securities Investments	2,811,932	US$33.2m	-5.43%	0.02%
0.91%	JP Morgan Asset Management	2,528,886	US$29.8m	-4.09%	no data
0.9%	Credit Suisse Asset Management (Switzerland) Ltd.	2,500,082	US$29.5m	-0.1%	0.02%
0.78%	Northern Trust Global Investments	2,182,877	US$25.8m	9.52%	no data
0.76%	Long Focus Capital Management LLC	2,135,521	US$25.2m	-13.6%	3.1%
0.75%	Palo Alto Investors LP	2,106,792	US$24.9m	0%	2.73%
0.72%	Principal Global Investors, LLC	2,006,403	US$23.7m	-23.9%	0.01%
0.72%	Hood River Capital Management LLC	2,001,510	US$23.6m	0.46%	0.6%
0.69%	Deutsche Asset & Wealth Management	1,915,412	US$22.6m	281%	0.01%